Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Pecci

Showing results (11-20 of 121) with videos related to

Pageof 13
Sort By:
British Journal of Haematology|May 6, 2011
Recent advances in the understanding and management of MYH9-related inherited thrombocytopeniasCarlo L Balduini, Alessandro Pecci, Anna Savoia
Seminars in Thrombosis and Hemostasis|February 12, 2013
Diagnosis and management of inherited thrombocytopeniasCarlo Luigi Balduini, Alessandro Pecci, Patrizia Noris
Acta Haematologica|December 18, 2002
Apoptosis in relation to CD34 antigen expression in normal and myelodysplastic bone marrowAlessandro Pecci, Erica Travaglino, Catherine Klersy, et al.
Minerva Medica|May 14, 2021
Management of Lemierre SyndromeLuca Valerio, William Pleming, Alessandro Pecci, et al.
Internal and Emergency Medicine|September 1, 2006
Peripheral arteriopathy of the lower limbs in a patient with severe congenital thrombocytopeniaDaniela Poli, Alessandro Pecci, Patrizia Noris, et al.
Thrombosis and Haemostasis|March 9, 2012
Short-term eltrombopag for surgical preparation of a patient with inherited thrombocytopenia deriving from MYH9 mutationAlessandro Pecci, Serena Barozzi, Salvatore d'Amico, et al.
Gene|April 22, 2018
MYH9: Structure, functions and role of non-muscle myosin IIA in human diseaseAlessandro Pecci, Xuefei Ma, Anna Savoia, et al.
American Journal of Hematology|July 24, 2013
Cutaneous involvement by post-polycythemia vera myelofibrosisAlessandro Pecci, Giorgio Croci, Carlo L Balduini, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 27, 2008
Renin-angiotensin system blockade is effective in reducing proteinuria of patients with progressive nephropathy caused by MYH9 mutations (Fechtner-Epstein syndrome)Alessandro Pecci, Antonio Granata, Carmelo E Fiore, et al.
Kidney International|April 14, 2012
The case ∣ proteinuria and low platelet countGiorgina B Piccoli, Federica N Vigotti, Carlo L Balduini, et al.
Pageof 13

Showing results (11-20 of 121) with videos related to

Sort By:
Pageof 13
British Journal of Haematology|May 6, 2011
Recent advances in the understanding and management of MYH9-related inherited thrombocytopeniasCarlo L Balduini, Alessandro Pecci, Anna Savoia
Seminars in Thrombosis and Hemostasis|February 12, 2013
Diagnosis and management of inherited thrombocytopeniasCarlo Luigi Balduini, Alessandro Pecci, Patrizia Noris
Acta Haematologica|December 18, 2002
Apoptosis in relation to CD34 antigen expression in normal and myelodysplastic bone marrowAlessandro Pecci, Erica Travaglino, Catherine Klersy, et al.
Minerva Medica|May 14, 2021
Management of Lemierre SyndromeLuca Valerio, William Pleming, Alessandro Pecci, et al.
Internal and Emergency Medicine|September 1, 2006
Peripheral arteriopathy of the lower limbs in a patient with severe congenital thrombocytopeniaDaniela Poli, Alessandro Pecci, Patrizia Noris, et al.
Thrombosis and Haemostasis|March 9, 2012
Short-term eltrombopag for surgical preparation of a patient with inherited thrombocytopenia deriving from MYH9 mutationAlessandro Pecci, Serena Barozzi, Salvatore d'Amico, et al.
Gene|April 22, 2018
MYH9: Structure, functions and role of non-muscle myosin IIA in human diseaseAlessandro Pecci, Xuefei Ma, Anna Savoia, et al.
American Journal of Hematology|July 24, 2013
Cutaneous involvement by post-polycythemia vera myelofibrosisAlessandro Pecci, Giorgio Croci, Carlo L Balduini, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 27, 2008
Renin-angiotensin system blockade is effective in reducing proteinuria of patients with progressive nephropathy caused by MYH9 mutations (Fechtner-Epstein syndrome)Alessandro Pecci, Antonio Granata, Carmelo E Fiore, et al.
Kidney International|April 14, 2012
The case ∣ proteinuria and low platelet countGiorgina B Piccoli, Federica N Vigotti, Carlo L Balduini, et al.
Pageof 13